Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

EPZ020411

SKU: orb1225961

Description

EPZ020411 is a potent, selective PRMT6 inhibitor with IC50 of 10 nM, displays 10-fold and 20-fold selectivity over PRMT1/8, and >100-fold over other histone methyltransferases (PRMT3/4/5/7); dose-dependently decreases H3R2 methylation A375 cell line with IC50 of 0.637 uM, with no affect levels of PRMT6 expression; exhibits good bioavailability following subcutaneous dosing in rats making it a suitable tool for potential in vivo target validation studies.

Images & Validation

Key Properties

CAS Number1700663-41-7
MW442.5942
Purity>98% (HPLC)
FormulaC25H38N4O3
SMILESCNCCN(C)CC1=C(NN=C1)C2=CC=C(C=C2)OC3CC(C3)OCCC4CCOCC4
TargetHMTase
Solubility10 mM in DMSO

Bioactivity

In Vivo
EPZ020411 (10 mg/kg; i.p. once) reduces neomycin-and cisplatin-induced hearing loss in C57BL/6J wild-type mice with acute ototoxicity model. Pharmacokinetic Parameters of EPZ020411 in rats. Animal model: C57BL/6J wild-type mice at P28 with acute ototoxicity model. Dosage: 10 mg/kg. Administration: Intraperitoneal injection; 10 mg/kg once. Result: Significantly reduced neomycin-and cisplatin-induced HC loss and showed no effect without neomycin injection with mice.
In Vitro
EPZ020411 (0-20 μM; 24 h) decreases H3R2 methylation in A375 cells. EPZ020411 (20-40 μM; 6 h) reduces neomycin- and cisplatin-induced cell apoptosis and increases hair cell survival. Western blot analysis. Cell line: A375 cells. Concentration: 0-20 μM. Incubation time: 24 hours. Result: Dose-dependently decreased H3R2 methylation in A375 cells with an IC50 of 0.634 μM. Apoptosis Analysis Cell line: Cultured cochleae cells. Concentration: 20-40 μM. Incubation time: 6 hours. Result: Suppressed the apoptotic cascade induced by aminoglycosides and also inhibited cisplatin-induced apoptosis in the hair cells of the cochlear explants after pretreatment deposed. Also reduced hair cell loss caused by cisplatin treatment.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

EPZ-020411

Similar Products

  • EPZ020411 2HCl [orb1690001]

    99.20% (May vary between batches)

    2095432-47-4

    515.51

    C25H40Cl2N4O3

    2 mg, 5 mg, 10 mg, 25 mg, 1 ml x 10 mM (in DMSO)
  • EPZ020411 [orb1984332]

    1700663-41-7

    442.6

    C25H38N4O3

    2 mg, 5 mg, 10 mg
  • EPZ020411 hydrochloride [orb1704829]

    99.88% (May vary between batches)

    2070015-25-5

    479.05

    C25H39ClN4O3

    1 mg, 10 mg, 25 mg, 50 mg, 100 mg, 5 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

EPZ020411 (orb1225961)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

100 mg
200 mg
500 mg
5 mg
$ 330.00
10 mg
$ 530.00